Soleno Therapeutics Inc
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. Show More...
-
Website https://soleno.life
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 73.35 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -23.13 -13.23 -52.1 -8.45 -5.07 -1.71 -0.64 -0.9 -0.81 Dividends USD Payout Ratio % * Shares Mil 2.0 3.0 9.0 21.0 34.0 37.0 Book Value Per Share * USD -31.3 -0.46 1.7 1.21 0.45 0.33 0.21 Free Cash Flow Per Share * USD -2.82 -3.53 -4.84 -1.32 -0.59 -0.54 Return on Assets % -257.82 -180.81 -277.97 -191.7 -228.34 -70.28 -32.46 -75.68 -83.41 Financial Leverage (Average) 2.54 1.62 1.47 1.42 2.55 3.39 Return on Equity % -472.03 -104.55 -46.83 -135.69 -178.8 Return on Invested Capital % -472.03 -104.55 -46.83 -133.89 -175.46 Interest Coverage -1.26 -0.3 -2.36 Current Ratio 0.21 0.11 6.46 2.01 2.23 10.38 13.14 4.26 2.15 Quick Ratio 0.2 0.1 6.16 1.77 1.67 9.87 12.86 4.18 2.07 Debt/Equity